(1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-YL)-1-propanolmethanesulfonate trihydrate

(1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-YL)-1-propanolmethanesulfonate trihydrate

PCT No. PCT/IB96/00592 Sec. 371 Date May 7, 1998 Sec. 102(e) Date May 7, 1998 PCT Filed Jun. 20, 1996 PCT Pub. No. WO97/07098 PCT Pub. Date Feb. 27, 1997The invention relates to the trihydrate of the mesylate salt of (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol, pharma...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MARTA M. ANDINO, EUGENE F. FIESE, TERRY G. SINARY
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PCT No. PCT/IB96/00592 Sec. 371 Date May 7, 1998 Sec. 102(e) Date May 7, 1998 PCT Filed Jun. 20, 1996 PCT Pub. No. WO97/07098 PCT Pub. Date Feb. 27, 1997The invention relates to the trihydrate of the mesylate salt of (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol, pharmaceutical compositions containing said compound and methods of treating disorders of the central nervous system by administering said compound.